Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
2 |
12 |
9 |
NM_140151.2 |
CG11811-RA (CG11811), mRNA |
1.45 |
7 |
30 |
48 |
67 |
NM_169851.1 |
CG31475-RA (CG31475), mRNA |
1.24 |
6 |
14 |
31 |
30 |
NM_058028.3 |
CG4585-RA (CG4585), mRNA |
1.03 |
5 |
29 |
63 |
132 |
NM_141639.1 |
CG16779-RA (CG16779), mRNA |
1.03 |
5 |
3 |
59 |
147 |
NM_136647.2 |
CG8809-RA (Camta), mRNA |
0.82 |
4 |
8 |
9 |
23 |
NM_079905.2 |
CG12127-RA (amx), mRNA |
0.82 |
4 |
3 |
36 |
59 |
NM_206458.2 |
CG17816-RD, transcript variant D (CG17816), mRNA |
0.82 |
4 |
3 |
36 |
59 |
NM_169199.1 |
CG17816-RA, transcript variant A (CG17816), mRNA |
0.82 |
4 |
3 |
36 |
59 |
NM_169198.1 |
CG17816-RB, transcript variant B (CG17816), mRNA |
0.82 |
4 |
3 |
36 |
59 |
NM_141487.2 |
CG17816-RC, transcript variant C (CG17816), mRNA |
0.62 |
3 |
33 |
80 |
150 |
NM_143765.2 |
CG12218-RA (mei-P26), mRNA |
0.62 |
3 |
30 |
76 |
153 |
NM_165217.1 |
CG6667-RA, transcript variant A (dl), mRNA |
0.62 |
3 |
30 |
76 |
153 |
NM_165218.1 |
CG6667-RB, transcript variant B (dl), mRNA |
0.62 |
3 |
23 |
114 |
150 |
NM_134763.1 |
CG14351-RA (CG14351), mRNA |
0.62 |
3 |
20 |
51 |
74 |
NM_132420.2 |
CG32676-RA (CG32676), mRNA |
0.62 |
3 |
13 |
53 |
143 |
NM_167330.2 |
CG17762-RD, transcript variant D (tomosyn), mRNA |
0.62 |
3 |
12 |
18 |
55 |
NM_167329.2 |
CG17762-RC, transcript variant C (tomosyn), mRNA |
0.62 |
3 |
12 |
18 |
52 |
NM_167328.2 |
CG17762-RA, transcript variant A (tomosyn), mRNA |
0.62 |
3 |
8 |
15 |
21 |
NM_165979.1 |
CG32843-RA (CG32843), mRNA |
0.62 |
3 |
7 |
8 |
14 |
NM_132125.1 |
CG4536-RA (CG4536), mRNA |
0.62 |
3 |
4 |
56 |
62 |
NM_164960.1 |
CG32830-RA (CG32830), mRNA |
0.62 |
3 |
4 |
8 |
45 |
NM_144311.1 |
CG15494-RA (CG15494), mRNA |
0.62 |
3 |
3 |
27 |
33 |
NM_130646.2 |
CG14045-RA (CG14045), mRNA |
0.62 |
3 |
3 |
12 |
26 |
NM_134892.2 |
CG17264-RA (CG17264), mRNA |
0.62 |
3 |
2 |
13 |
30 |
NM_057403.3 |
CG5753-RA, transcript variant A (stau), mRNA |
0.62 |
3 |
2 |
12 |
25 |
NM_166263.1 |
CG5753-RB, transcript variant B (stau), mRNA |
0.41 |
2 |
37 |
49 |
117 |
NM_078516.2 |
CG12690-RA (CHES-1-like), mRNA |
0.41 |
2 |
36 |
109 |
180 |
NM_079853.2 |
CG15532-RA, transcript variant A (hdc), mRNA |
0.41 |
2 |
36 |
109 |
180 |
NM_176591.1 |
CG15532-RC, transcript variant C (hdc), mRNA |
0.41 |
2 |
35 |
23 |
36 |
NM_130512.2 |
CG11663-RA (CG11663), mRNA |
|